Answers are grounded in this paper and cite their sources.
Systematic review identifies cannabinoids as a potential treatment for BPSD in dementia, suggesting improved outcomes.
Background: Behavioral and psychological symptoms of dementia (BPSD) affect patients’ and caregivers’ well-being. Cannabinoids may offer a promising therapeutic option for managing BPSD. Aims: This systematic review aims to explore the strengths of using this class of substances in the context of dementia care. Methods: We conducted a comprehensive search across Embase Ovid, PubMed, Cochrane Library, APA PsycInfo, and Web of Science, identifying 1839 studies, with 14 selected for full review. Quality was assessed using the Newcastle–Ottawa and the modified Jadad Scales. Results/Outcomes: Ten studies (278 participants) were finally included. They showed cannabinoids helped reduce agitation and nocturnal disturbances. Conclusions/Interpretation: In conclusion, cannabinoids show promise in managing BPSD in dementia, with good tolerability and safety. Further studies could solidify these findings.
No takes yet. Share an insight, caveat, or question.
Ravelli et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: